![](/img/cover-not-exists.png)
Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
Guerrab, Abderrahim El, Bamdad, Mahchid, Kwiatkowski, Fabrice, Bignon, Yves-Jean, Penault-Llorca, Frédérique, Aubel, CorinneVolume:
7
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.12037
Date:
November, 2016
File:
PDF, 5.08 MB
english, 2016